Publication | Open Access

Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway

MedicineCombinatorial TherapyAdenoviral-mediated PtenPi3k InhibitorAnti-cancer AgentCell BiologyCancer TreatmentTumor SuppressorPharmacologyGliomaTumor BiologyCancer Growth